The estimated Net Worth of Daniel Calkins is at least $138 ezer dollars as of 9 July 2024. Daniel Calkins owns over 7 units of Verastem Inc stock worth over $133,168 and over the last 2 years Daniel sold VSTM stock worth over $5,312.
Daniel has made over 17 trades of the Verastem Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Daniel sold 7 units of VSTM stock worth $18 on 9 July 2024.
The largest trade Daniel's ever made was selling 1,246 units of Verastem Inc stock on 27 December 2022 worth over $411. On average, Daniel trades about 117 units every 28 days since 2022. As of 9 July 2024 Daniel still owns at least 47,560 units of Verastem Inc stock.
You can see the complete history of Daniel Calkins stock trades at the bottom of the page.
Daniel's mailing address filed with the SEC is C/O VERASTEM, INC., 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494.
Over the last 13 years, insiders at Verastem Inc have traded over $5,883,823 worth of Verastem Inc stock and bought 3,873,819 units worth $28,318,633 . The most active insiders traders include Capital Management, L.P.Ra ..., Christoph H Westphal és Ansbert Gadicke. On average, Verastem Inc executives and independent directors trade stock every 28 days with the average trade being worth of $112,479. The most recent stock trade was executed by Dan Paterson on 5 August 2024, trading 3,245 units of VSTM stock currently worth $7,009.
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
Verastem Inc executives and other stock owners filed with the SEC include: